首页> 外文期刊>Tropical Journal of Pharmaceutical Research >Novel hydroquinone derivatives alleviate algesia, inflammation and pyrexia in the absence of gastric ulcerogenicity
【24h】

Novel hydroquinone derivatives alleviate algesia, inflammation and pyrexia in the absence of gastric ulcerogenicity

机译:新型对苯二酚衍生物可在没有胃溃疡的情况下缓解痛觉过敏,炎症和发热

获取原文
           

摘要

Purpose: To synthesize and characterize novel hydroquinone compounds that exhibit an aspirin-like pharmacological profile devoid of ulcerogenic side effects. Methods: Two novel hydroquinone derivatives, viz, 2,5-bis(piperidinomethyl)hydroquinone and 2,5-bis(pyrrolidinomethyl)hydroquinone, were synthesized by refluxing hydroquinone, paraformaldehyde and secondary amines (piperidine or pyrrolidine) in ethanol. The structures were authenticated by infrared (IR) spectroscopy, elemental analysis, mass spectrometry (MS) and 1H and 13C nuclear magnetic resonance (NMR) spectroscopic techniques. The synthesized derivatives were evaluated for antinociceptive, anti-inflammatory and antipyretic activities along with gastric-ulcerogenicity using well-known testing paradigms. Aspirin served as reference standard. Results: The newly synthesized hydroquinone derivatives, significantly attenuated tonic visceral chemically-induced nociception at 10 mg/kg (p 0.01, p 0.001), 20 and 40 mg/kg (p 0.001), inhibited the temporal-inflammatory reaction at 50 mg/kg (2 - 5 h, p 0.05, p 0.001), 100 and 150 mg/kg (1 - 5 h, p 0.05, p 0.01, p 0.001) in addition to alleviating the febrile-response at test doses during 0.5 h (p 0.05, p 0.01, p 0.001), 1 and 1.5 h (p 0.001) of the study period. The synthesized compounds exhibited improved gastric tolerability profile since they were devoid of aspirin-associated biochemical and ulcerative changes. The in silico studies predicted high binding affinity of the hydroquinone derivatives to the active site of the cyclooxygenase 2 (COX-2) enzyme. Conclusion: The synthesized hydroquinone compounds possess analgesic, antipyretic and anti-inflammatory properties with low gastric-ulcerogenic potential. This may be credited to preferential inhibition of the COX-2 enzyme and the beneficial basic rather than acidic chemical nature of the compounds. However, further molecular studies are required to substantiate these findings.
机译:目的:合成和表征新颖的对苯二酚化合物,这些化合物表现出类似阿司匹林的药理特性,而没有引起溃疡的副作用。方法:通过将对苯二酚,多聚甲醛和仲胺(哌啶或吡咯烷)在乙醇中回流,合成了两种新颖的对苯二酚衍生物,即2,5-双(哌啶子基甲基)氢醌和2,5-双(吡咯烷基甲基)氢醌。通过红外(IR)光谱,元素分析,质谱(MS)以及1H和13C核磁共振(NMR)光谱技术对结构进行鉴定。使用众所周知的测试范例对合成的衍生物的抗伤害感受,抗炎和解热活性以及胃溃疡致病性进行了评估。阿司匹林作为参考标准。结果:新合成的对苯二酚衍生物在10 mg / kg(p <0.01,p <0.001),20和40 mg / kg(p <0.001)时显着减弱了强直性内脏化学诱导的伤害感受,抑制了短暂的炎症反应。 50毫克/公斤(2-5小时,p <0.05,p <0.001),100和150毫克/公斤(1-5小时,p <0.05,p <0.01,p <0.001),在研究期的0.5 h(p <0.05,p <0.01,p <0.001),1和1.5 h(p <0.001)期间,在测试剂量下有明显反应合成的化合物由于没有阿司匹林相关的生化和溃疡性变化而显示出改善的胃耐受性。电子计算机研究预测对苯二酚衍生物对环氧合酶2(COX-2)酶的活性位点具有很高的结合亲和力。结论:合成的对苯二酚类化合物具有镇痛,解热,抗炎作用,胃溃疡发生潜力低。这可以归因于对COX-2酶的优先抑制和化合物的有益的碱性而非酸性化学性质。但是,需要进一步的分子研究来证实这些发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号